Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease

被引：32
作者：
Christopher Ma
Robert Battat
Vipul Jairath
Niels Vande Casteele
机构：
[1] University of Calgary,Division of Gastroenterology and Hepatology
[2] Robarts Clinical Trials,Division of Gastroenterology
[3] Inc.,Department of Medicine, Division of Gastroenterology
[4] University of California San Diego,Department of Epidemiology and Biostatistics
[5] Western University,Department of Medicine
[6] Western University,undefined
[7] University of California San Diego,undefined
来源：
Current Treatment Options in Gastroenterology | 2019年 / 17卷 / 1期
关键词：
Biologics; Crohn’s disease; Inflammatory bowel disease; Therapeutic drug monitoring; Thiopurines; Ulcerative colitis;
D O I：
10.1007/s11938-019-00222-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 145
页数：18
相关论文
共 607 条
  • [1] Duijvestein M(2018)Novel therapies and treatment strategies for patients with inflammatory bowel disease Curr Treat Options Gastroenterol 16 129-146
  • [2] Battat R(2013)Optimizing biologic therapy for treatment of inflammatory bowel disease Gastroenterol Hepatol (N Y) 9 462-464
  • [3] Vande Casteele N(2016)Loss of response to anti-TNFs: definition, epidemiology, and management Clin Transl Gastroenterol 7 e135-698
  • [4] D'Haens GR(2011)Assessing response and loss of response to biological therapies in IBD Am J Gastroenterol 106 685-1545
  • [5] Sandborn WJ(2015)The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease Gut 64 1539-558
  • [6] Khanna R(2008)Monoclonal antibody pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 84 548-1087
  • [7] Van Assche G(2012)Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease Clin Gastroenterol Hepatol 10 1079-1718
  • [8] Roda G(2015)Therapeutic drug monitoring of anti-tumor necrosis factor agents in patients with inflammatory bowel diseases Inflamm Bowel Dis 21 1709-197
  • [9] Jharap B(2017)A survey study of gastroenterologists’ attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease Inflamm Bowel Dis 24 191-834
  • [10] Neeraj N(2017)American Gastroenterological Association Institute Clinical Guidelines C. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease Gastroenterology 153 827-713
12345678910